SurModics Inc. (NASDAQ:SRDX) CEO Gary R. Maharaj sold 5,000 shares of the company’s stock in a transaction on Monday, November 7th. The shares were sold at an average price of $25.22, for a total value of $126,100.00. Following the completion of the sale, the chief executive officer now owns 130,207 shares in the company, valued at $3,283,820.54. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Gary R. Maharaj also recently made the following trade(s):

  • On Monday, October 3rd, Gary R. Maharaj sold 5,000 shares of SurModics stock. The shares were sold at an average price of $29.55, for a total value of $147,750.00.

SurModics Inc. (NASDAQ:SRDX) opened at 28.55 on Monday. The stock has a market capitalization of $372.43 million, a P/E ratio of 42.68 and a beta of 0.98. The company’s 50-day moving average price is $27.76 and its 200 day moving average price is $25.83. SurModics Inc. has a 52-week low of $17.45 and a 52-week high of $30.75.

Insider Buying and Selling by Quarter for SurModics (NASDAQ:SRDX)

A number of hedge funds have recently bought and sold shares of SRDX. Capstone Asset Management Co. boosted its position in shares of SurModics by 1.6% in the third quarter. Capstone Asset Management Co. now owns 8,780 shares of the company’s stock valued at $264,000 after buying an additional 140 shares during the period. California State Teachers Retirement System boosted its position in shares of SurModics by 1.1% in the third quarter. California State Teachers Retirement System now owns 27,414 shares of the company’s stock valued at $825,000 after buying an additional 300 shares during the period. First Quadrant L P CA boosted its position in shares of SurModics by 9.4% in the third quarter. First Quadrant L P CA now owns 4,374 shares of the company’s stock valued at $132,000 after buying an additional 374 shares during the period. Prudential Financial Inc. boosted its position in shares of SurModics by 0.9% in the first quarter. Prudential Financial Inc. now owns 46,162 shares of the company’s stock valued at $850,000 after buying an additional 400 shares during the period. Finally, BlackRock Group LTD boosted its position in shares of SurModics by 5.8% in the second quarter. BlackRock Group LTD now owns 16,841 shares of the company’s stock valued at $395,000 after buying an additional 930 shares during the period. Hedge funds and other institutional investors own 87.59% of the company’s stock.

Several analysts have recently issued reports on the company. Zacks Investment Research downgraded SurModics from a “buy” rating to a “hold” rating in a research report on Thursday, October 27th. Sidoti downgraded SurModics from a “buy” rating to a “neutral” rating and set a $33.00 target price on the stock. in a research report on Thursday, October 6th.

About SurModics

SurModics, Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company is focused on to transform its medical device business from being a provider of coating technologies to offering whole product solutions to medical device customers.

5 Day Chart for NASDAQ:SRDX

Receive News & Stock Ratings for SurModics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurModics Inc. and related stocks with our FREE daily email newsletter.